跳至主要内容
临床试验/NCT02498522
NCT02498522已完成早期 1 期

Effect of Metformin on Early Pregnancy Loss in Pregnant Women With Polycystic Ovarian Syndrome

Ain Shams University1 个研究点 分布在 1 个国家目标入组 166 人开始时间: 2015年8月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
早期 1 期
状态
已完成
入组人数
166
试验地点
1
主要终点
Miscarriage Rate

研究概览

简要总结

The aim of this work is to study the effect of metformin use for reducing early pregnancy loss in pregnant patients with Polycystic ovary syndrome (PCOS).

详细描述

Polycystic ovary syndrome (PCOS) is the most common endocrine disorder in women of reproductive age. PCOS produces symptoms in approximately 5 to 10% of women of reproductive age (12-45 years old) and is thought to be one of the leading causes of the female subfertility

  • The aim of this work is to study the effect of metformin use for reducing early pregnancy loss in pregnant patients with PCOS
  • Research question:

In pregnant women with PCOS, does metformin use decreases the rate of early pregnancy loss?

-Research hypothesis: In Pregnant women with PCOS, metformin may reduce the rate of early pregnancy loss.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

年龄范围
25 Years 至 35 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Age : 25 -
  • Pregnant patients in their 1st trimester with history of infertility due to PCOS confirmed by at least 2 of the following criteria ( Rotterdam Criteria )
  • At least twelve small follicles 2-9 mm in at least one ovary; diagnosed by ultra sound examination.
  • Symptoms or biochemical evidence of hyperandrogenism; diagnosed by examination and laboratory investigations.
  • Anovulation or oligo-ovulation with fewer than nine menstrual periods every 12 months : diagnosed by thorough history taking.
  • Non diabetic patients who received metformin along with other ovulation-inducing drugs prior to pregnancy.

排除标准

  • patients with other causes of infertility other than PCOS
  • contraindications to metformin : liver impairment , renal failure.
  • Patients with PCOS who didn't receive Metformin with drugs of induction of ovulation before pregnancy.

研究组 & 干预措施

control arm

Placebo Comparator

83 patients will stop metformin at diagnosis of pregnancy ( 5-6 weeks gestation)

干预措施: Metformin (Drug)

metformin arm

Experimental

83 patients will continue metformin until end of 1st trimester (14 weeks gestation)

干预措施: Metformin (Drug)

结局指标

主要结局

Miscarriage Rate

时间窗: 6 months

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Islam Dabbous

doctor

Ain Shams University

研究点 (1)

Loading locations...

相似试验